Relay Therapeutics, Inc.RLAYNASDAQ
Loading
Cost of Revenue Over TimeStable
Percentile Rank57
5Y CAGR-17.6%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

5Y CAGR
-17.6%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthStable
PeriodValueYoY Change
TTM$1.35M-
2024$0.00-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$3.55M+24.7%
2019$2.85M+32.1%
2018$2.15M-